These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38222744)

  • 1. End-organ damage due to iron overload related to blood transfusion in an 11-year-old male.
    Chreitah A; Aljanati O; Bress F; Jamahiri B; Alkilany Z; Assaf S
    Ann Med Surg (Lond); 2024 Jan; 86(1):575-579. PubMed ID: 38222744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.
    Fisher SA; Brunskill SJ; Doree C; Gooding S; Chowdhury O; Roberts DJ
    Cochrane Database Syst Rev; 2013 Aug; (8):CD004450. PubMed ID: 23963793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.
    Roberts DJ; Rees D; Howard J; Hyde C; Alderson P; Brunskill S
    Cochrane Database Syst Rev; 2005 Oct; (4):CD004450. PubMed ID: 16235363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron overload after pediatric liver transplantation: a case report.
    Wakiya T; Sanada Y; Urahashi T; Ihara Y; Yamada N; Okada N; Toyoki Y; Hakamada K; Mizuta K
    Transplant Proc; 2014 Apr; 46(3):973-6. PubMed ID: 24767394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral deferiprone for iron chelation in people with thalassaemia.
    Fisher SA; Brunskill SJ; Doree C; Chowdhury O; Gooding S; Roberts DJ
    Cochrane Database Syst Rev; 2013 Aug; (8):CD004839. PubMed ID: 23966105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron overload and glucose metabolism in subjects with β-thalassaemia major: an overview.
    De Sanctis V; Soliman A; Yassin M
    Curr Diabetes Rev; 2013 Jul; 9(4):332-41. PubMed ID: 23687960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of iron overload in the pediatric patient.
    Cohen A
    Hematol Oncol Clin North Am; 1987 Sep; 1(3):521-44. PubMed ID: 3329185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Iron Overload Between Age Groups Using Magnetic Resonance Imaging and Its Correlation with Iron Profile in Transfusion-dependent Thalassemia.
    Wahidiyat PA; Iskandar SD; Sekarsari D
    Acta Med Indones; 2018 Jul; 50(3):230-236. PubMed ID: 30333273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New pharmacological concepts for the treatment of iron overload disorders.
    Mair SM; Weiss G
    Curr Med Chem; 2009; 16(5):576-90. PubMed ID: 19199923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe Liver Iron Concentrations (LIC) in 24 Patients with β-Thalassemia Major: Correlations with Serum Ferritin, Liver Enzymes and Endocrine Complications.
    Kanbour I; Chandra P; Soliman A; De Sanctis V; Nashwan A; Abusamaan S; Moustafa A; Yassin MA
    Mediterr J Hematol Infect Dis; 2018; 10(1):e2018062. PubMed ID: 30416694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Massive iron overload and acute-on-chronic liver failure in a patient with Diamond-Blackfan anaemia: a case report.
    Assis-Mendonça GR; Cunha-Silva M; Fernandes MF; Torres LD; de Almeida Verissimo MP; Okano MTN; Mazo DF; Lalli CA; Sevá-Pereira T; Stelini RF; da Costa LBE
    BMC Gastroenterol; 2020 Oct; 20(1):332. PubMed ID: 33045993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of the influence of iron overload in glucose metabolism in thalassemia major patients].
    Liang LY; Lao WQ; Meng Z; Zhang LN; Hou LL; Ou H; Liu ZL; He ZW; Luo XY; Fang JP
    Zhonghua Er Ke Za Zhi; 2017 Jun; 55(6):419-422. PubMed ID: 28592008
    [No Abstract]   [Full Text] [Related]  

  • 14. Neonatal hemochromatosis with εγδβ-thalassemia: a case report and analysis of serum iron regulators.
    Tsuge M; Kodera A; Sumitomo H; Araki T; Yoshida R; Yasui K; Sato H; Washio Y; Washio K; Shigehara K; Yashiro M; Yagi T; Tsukahara H
    BMC Pediatr; 2022 Oct; 22(1):622. PubMed ID: 36309641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylated ferritin as an improved marker for post-transfusion iron overload.
    Ishihara A; Yamauchi T; Ikeda K; Fukuyoshi Y; Yokoyama T; Yonemura Y; Uchiba M; Matsui H
    Int J Hematol; 2021 Apr; 113(4):537-546. PubMed ID: 33400141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How we manage iron overload in sickle cell patients.
    Coates TD; Wood JC
    Br J Haematol; 2017 Jun; 177(5):703-716. PubMed ID: 28295188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety profile of a liquid formulation of deferiprone in young children with transfusion-induced iron overload: a 1-year experience.
    Chuansumrit A; Songdej D; Sirachainan N; Wongwerawattanakoon P; Kadegasem P; Sasanakul W
    Paediatr Int Child Health; 2016 Aug; 36(3):209-13. PubMed ID: 26052612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelodysplastic syndromes and the role of iron overload.
    Harvey RD
    Am J Health Syst Pharm; 2010 Apr; 67(7 Suppl 2):S3-9. PubMed ID: 20332503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
    Wang WC; Dwan K
    Cochrane Database Syst Rev; 2013 Nov; (11):CD003146. PubMed ID: 24226646
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.